Related Experiment Video
Updated: Aug 5, 2025
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating
Mohamad Hamieh1,2, Jorge Mansilla-Soto1,2, Isabelle Rivière1,3,4
1Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract:
The success of chimeric antigen receptor (CAR) T cells targeting B-cell malignancies propelled the field of synthetic immunology and raised hopes to treat solid tumors in a similar fashion. Antigen escape and the paucity of tumor-restricted CAR targets are recognized challenges to fulfilling this prospect. Recent advances in CAR T cell engineering extend the toolbox of chimeric receptors available to calibrate antigen sensitivity and combine receptors to create adapted tumor-sensing T cells. Emerging engineering strategies to lower the threshold for effective antigen recognition, when needed, and enable composite antigen recognition hold great promise for overcoming tumor heterogeneity and curbing off-tumor toxicities.
Significance:
Improving the clinical efficacy of CAR T cell therapies will require engineering T cells that overcome heterogeneous and low-abundance target expression while minimizing reactivity to normal tissues. Recent advances in CAR design and logic gating are poised to extend the success of CAR T cell therapies beyond B-cell malignancies.
Insights
Chimeric antigen receptor (CAR) T cell engineering advances offer new strategies to overcome challenges in treating solid tumors. These innovations aim to improve CAR T cell efficacy against heterogeneous tumors while minimizing side effects.
Area of Science:
- Synthetic immunology
- Immunotherapy
- Cancer research
Background:
- Chimeric antigen receptor (CAR) T cells have shown success in treating B-cell malignancies.
- Challenges remain for CAR T cells in solid tumors, including antigen escape and lack of specific targets.
- Engineering CAR T cells is crucial for improving clinical efficacy and safety.
Purpose of the Study:
- To explore recent advances in CAR T cell engineering for treating solid tumors.
- To address challenges of antigen escape and target specificity in solid tumor immunotherapy.
- To highlight strategies for enhancing CAR T cell recognition and reducing off-tumor toxicities.
Main Methods:
- Engineering chimeric receptors to calibrate antigen sensitivity.
- Developing logic-gated CAR T cells for precise tumor targeting.
- Implementing strategies to lower antigen recognition thresholds when necessary.
Main Results:
- Advanced CAR T cell engineering provides tools to overcome tumor heterogeneity.
- New designs enable composite antigen recognition for improved tumor targeting.
- Strategies are emerging to minimize reactivity to normal tissues, reducing toxicity.
Conclusions:
- Advances in CAR T cell design and logic gating hold promise for extending CAR T cell therapy beyond blood cancers.
- Engineering CAR T cells to overcome target expression variability and minimize off-tumor effects is key to future success.
- Novel CAR T cell engineering approaches are critical for realizing the potential of immunotherapy in solid tumors.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
Related Concept Videos
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Tumor Immunotherapy
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...